You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

33 search results for: remission

ADVENT On Air | What Is the Future Outlook for <b>Remission</b> in Pediatric Severe Asthma?

Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

24 min

Pulmonology

Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.

ERS 2024 | Understanding <b>Remission</b> as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

5 min

Pulmonology

In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier revisits a patient case study where a biologic has been added to an asthma management plan and describes the potential for this patient to achieve on-therapy clinical remission.

Can Chronic Rhinosinusitis With Nasal Polyps be Considered in <b>Remission</b> if the Patient has an Impaired Sense of Smell?

expert video

Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?

5 min

Rhinology

Dr. Backer discusses assessing remission in CRSwNP by evaluating the patient's sense of smell in this video clip from the EAACI 2024 symposium.

ERS 2024 | Understanding <b>Remission</b> as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction

expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction

10 min

Pulmonology

In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier describes a typical patient presentation in the pediatric asthma clinic and explores whether clinical remission is a goal of treatment for this patient and others like them.

expert video

ERS 2024 | Panel Discussion: What Might Be Required for On-Therapy Remission in Pediatric Severe Asthma?

10 min

Pulmonology

In this ADVENT symposium at the 2024 European Respiratory Society conference, Drs. Sharon Dell and Leonard Bacharier discuss the potential domains of on therapy clinical remission in pediatric severe asthma, emphasizing lung function as a key parameter for children.

IRS-ISIAN 2024 | <b>Remission</b> in CRSwNP: A Real-World Perspective

expert video

IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective

8 min

Rhinology

Prof. Eugenio De Corso describes the importance of real-world evidence for understanding the prospects of remission and the emerging evidence of biologic effectiveness for patients with CRSwNP.

Current systemic therapies have been shown to induce <b>remission</b> in a subset of AD patients

expert video

Current systemic therapies have been shown to induce remission in a subset of AD patients

5 min

Dermatology

Dr. Ramien discusses evidence suggesting early targeted inhibition in pediatric patients may prevent disease progression or lead to remission.

expert video

ERS 2023 | Adult Asthma Symposium: Mini Debate

3 min

Pulmonology

Prof. Ian Pavord moderates a debate between Prof. Vibeke Backer and Dr. Francesca Puggioni about what a patient's lung function should be in order to be defined as achieving clinical remission in adult asthma.

The Impact of Advanced Systemic Therapies on Disease Control and Potential <b>Remission</b> in Atopic Dermatitis

expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

10 min

Dermatology

Exploring the concept of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis.

expert video

ERS 2023 | Advancing Asthma Management Beyond Control

12 min

Pulmonology

Prof. Ian Pavord discusses the current proposed framework for clinical remission in severe asthma.

expert video

ERS 2023 | Adult Asthma Symposium: Panel Discussion

9 min

Pulmonology

Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni and audience members share their views on the proposed framework for clinical remission in severe asthma.

expert video

ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management

4 min

Pulmonology

Prof. Vibeke Backer discusses the predictive and prognostic importance of the various biomarkers of type 2 inflammation in adult asthma.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region